Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Flexus Biosciences
is defunct.
Bought by BMS, Feb 2015, $800M + $450M milestones
------------------
If you believe any of this information is incorrect, please
let us know
.